Search company, investor...

Predict your next investment

Venture Capital

GeneChem Therapeutics Venture Fund

Are you an investor?

Submit your portfolio details now to be considered in our investor rankings.

Submit portfolio details

Investments

5

Portfolio Exits

1

About GeneChem Therapeutics Venture Fund

GeneChem Therapeutics Venture Fund focuses on the management of biotechnology venture capital funds, operating within the biotechnology and investment sectors. The company's main service is investing in businesses involved in drug discovery and development. The primary sectors are the biotechnology and pharmaceutical industries. It is based in Montreal, Canada.

Headquarters Location

1 Westmount Square Suite 800

Montreal, Quebec, H3Z 2P9,

Canada

514-849-7696

Are you an investor?

Submit your portfolio details now to be considered in our investor rankings.

Submit portfolio details

GeneChem Therapeutics Venture Fund Investments

5 Investments

GeneChem Therapeutics Venture Fund has made 5 investments. Their latest investment was in CoImmune as part of their Debt - III on July 7, 2011.

GeneChem Therapeutics Venture Fund Investments Activity

investments chart

Date	Round	Company	Amount	New?	Co-Investors	Sources
7/22/2011	Debt - III	CoImmune	$3.5M	No	Aurora Funds, Forbion, InterSouth Partners, Lumira Ventures, and TVM Capital Life Science
9/13/2010	Debt - II	Subscribe to see more	$99M	Subscribe to see more	Subscribe to see more	0
11/21/2008	Series C - II	Subscribe to see more	$99M	Subscribe to see more	Subscribe to see more	0
4/14/2008	Series C	Subscribe to see more		Subscribe to see more	Subscribe to see more	0
9/19/2001	Series B	Subscribe to see more	$99M	Subscribe to see more	Subscribe to see more	0

Date	7/22/2011	9/13/2010	11/21/2008	4/14/2008	9/19/2001
Round	Debt - III	Debt - II	Series C - II	Series C	Series B
Company	CoImmune	Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more
Amount	$3.5M	$99M	$99M		$99M
New?	No	Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more
Co-Investors	Aurora Funds, Forbion, InterSouth Partners, Lumira Ventures, and TVM Capital Life Science	Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more
Sources		0	0	0	0

GeneChem Therapeutics Venture Fund Portfolio Exits

1 Portfolio Exit

GeneChem Therapeutics Venture Fund has 1 portfolio exit. Their latest portfolio exit was CoImmune on February 07, 2014.

Date	Exit	Companies	Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.	Acquirer	Sources
2/7/2014	IPO	CoImmune	$99M	Public	3

Date	2/7/2014
Exit	IPO
Companies	CoImmune
Valuation	$99M
Acquirer	Public
Sources	3

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.